Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid

By Ullén Anders   Lennartsson Lena   Harmenberg Ulrika   Hjelm-Eriksson Marie   Kälkner Karl Mikael   Lennernäs Bo   Nilsson Sten  

Acta Oncologica, Vol. 44, Iss. 6, 2005-09 ,pp. : 644-650

Informa Healthcare

Access to resources Recommend Favorite

Safety and Activity of the Combination of Pegylated Liposomal Doxorubicin and Weekly Docetaxel in Advanced Breast Cancer

By Morabito Alessandro  

Breast Cancer Research and Treatment, Vol. 86, Iss. 3, 2004-08 ,pp. : 249-258

Springer Publishing Company

Access to resources Recommend Favorite

Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 4, 2013-05 ,pp. : 654-662

Bentham Science Publishers

Access to resources Recommend Favorite

The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer

By Morgan Claire   Lewis Paul D.   Jones Rachel M.   Bertelli Gianfilippo   Thomas Gerry A.   Leonard Robert C. F.  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 669-677

Informa Healthcare

Access to resources Recommend Favorite

Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1551-1559

Spandidos Publications

Access to resources Recommend Favorite